Literature DB >> 33858828

Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy.

Amit Sethi1, Jing Miao2, Maria Alice V Willrich3, Jody L Frinack3, Daniel C Cattran4, Fernando C Fervenza5.   

Abstract

Entities:  

Keywords:  PLA2R complement; antibodies; factor H; membranous nephropathy

Mesh：

Substances：

Year:  2021        PMID： 33858828      PMCID： PMC8216609          DOI： 10.2215/CJN.16631020

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  5 in total

1.  Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.

Authors:  Fernando C Fervenza; Gerald B Appel; Sean J Barbour; Brad H Rovin; Richard A Lafayette; Nabeel Aslam; Jonathan A Jefferson; Patrick E Gipson; Dana V Rizk; John R Sedor; James F Simon; Ellen T McCarthy; Paul Brenchley; Sanjeev Sethi; Carmen Avila-Casado; Heather Beanlands; John C Lieske; David Philibert; Tingting Li; Lesley F Thomas; Dolly F Green; Luis A Juncos; Lada Beara-Lasic; Samuel S Blumenthal; Amy N Sussman; Stephen B Erickson; Michelle Hladunewich; Pietro A Canetta; Lee A Hebert; Nelson Leung; Jay Radhakrishnan; Heather N Reich; Samir V Parikh; Debbie S Gipson; Dominic K Lee; Bruno R da Costa; Peter Jüni; Daniel C Cattran
Journal:  N Engl J Med       Date:  2019-07-04       Impact factor: 91.245

2.  Factor H Autoantibodies and Membranous Nephropathy.

Authors:  Claudia Seikrit; Pierre Ronco; Hanna Debiec
Journal:  N Engl J Med       Date:  2018-12-20       Impact factor: 91.245

3.  More about Factor H Autoantibodies in Membranous Nephropathy.

Authors:  Elisabetta Valoti; Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2019-10-17       Impact factor: 91.245

Review 4.  Primary Membranous Nephropathy.

Authors:  William G Couser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-26       Impact factor: 8.237

5.  Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.

Authors:  Piero Ruggenenti; Hanna Debiec; Barbara Ruggiero; Antonietta Chianca; Timothee Pellé; Flavio Gaspari; Flavio Suardi; Elena Gagliardini; Silvia Orisio; Ariela Benigni; Pierre Ronco; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-03-24       Impact factor: 10.121
  5 in total
  1 in total

Review 1.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.